While elevated intraocular pressure (IOP) is the most commonly recognized modifiable risk factor for glaucoma, the role of IOP fluctuation throughout the day and night is being studied as a factor in glaucoma disease development and progression and management. IOP varies considerably during the 24-hour cycle. A single eye pressure measurement at any given time on any given day in
TGF News
Sustained-Release Glaucoma Medications
In recent years, the treatment of glaucoma has seen great advances with the introduction and growing use of minimally invasive glaucoma surgeries (MIGS). Now. on the horizon of innovative breakthroughs, are products that deliver a sustained release of glaucoma medications to lower eye pressure while offering an alternative to daily eye drop treatment. Compliance estimates for traditional drug therapy vary,
Clinical Trials/Studies Survey
Our recent survey on treatment options provided a wealth of valuable information - so much so, that the same pharmaceutical team would like to hear from you again - this time concerning your feelings about clinical trials and studies. If you would take a few minutes to give your input, please choose one of the options below and we'll direct you
Is my blood pressure linked to my eye pressure (IOP)?
[caption id="attachment_3457" align="aligncenter" width="270"] Question answered by:Gregory K. Harmon, MDBoard Chairman of The Glaucoma Foundation[/caption] Blood pressure and eye pressure vary independently. Controlling blood pressure does not mean IOP is controlled. But studies have shown that patients with high blood pressure have an increased risk for glaucoma. Very high blood pressure is not good for glaucoma. Moderate to very low blood
How to Qualify for Social Security Disability Benefits with Glaucoma
Glaucoma is a serious eye condition. It’s the number one cause of blindness and it can strike people who are as young as 40, even though it’s primarily thought of as something that affects mainly seniors. The fact is that more than a million people are diagnosed with glaucoma each year and for many of those people glaucoma makes it
Low Tech – High Tech: LOW VISION SOLUTIONS 101
Please join us and our panel of low-vision specialists and patient advocates for a live webinar with Q&A on May 27, Low Tech - High Tech: LOW VISION SOLUTIONS 101. We will be talking about a range of techniques and assets you can use to improve your home and work-life from simple low-tech methods and products to advanced optical and
TGF and RPB Announce New Grants
Research to Prevent Blindness and The Glaucoma Foundation Offer Critical Funding for Early-Career Vision Scientists NEW YORK, NY, April 14, 2021—Research to Prevent Blindness is pleased to announce a new round of grants, the Career Advancement Awards (CAAs), that support early-career researchers as they seek new knowledge related to eye diseases. The Award is aimed at early- to mid-career
New Grant Topic Announced
Forecasting Glaucoma Disease Progression with Artificial Intelligence MAJOR GAPS IN GLAUCOMA CARE: We currently have no way to forecast glaucoma disease progression or make predictions about whether patients will require incisional surgery or be blinded by glaucoma. Also, decisions about target IOP are arbitrary and based on clinical consideration of patient age, amount of baseline damage, and baseline IOP. The Glaucoma Foundation (TGF)
Ways to Look and Feel Your Best in 2021
[caption id="attachment_3261" align="aligncenter" width="300"] Photo Credit: Pexels[/caption] We’re coming out of a challenging year. Although vaccine distribution provides a light at the end of the tunnel, we still have a ways to go. Whether you’re stuck at home or safely navigating the world, it’s important to find ways to look and feel your best. These forms of self-care can give
New Fellowships Support Under-Represented Minorities in Glaucoma Research
The Glaucoma Foundation and Research to Prevent Blindness have partnered to provide five fellowships in 2021 to increase innovation and diversity in glaucoma research. NEW YORK, March 10, 2021 – The Glaucoma Foundation (TGF) and Research to Prevent Blindness (RPB) have partnered to launch a new grant aimed at supporting under-represented racial and ethnic minority researchers in the pursuit